You are here

drug pricing

US drug pricing reform in Inflation Reduction Act could harsh pharma's credit, Moody's says

US drug pricing reform in Inflation Reduction Act could harsh pharma's credit, Moody's says

Fierce Pharma

Inflation Reduction Act

Flag link:

Since Biden took over, Big Pharma has spent $205 million to protect drug price status quo, analysis finds

Since Biden took over, Big Pharma has spent $205 million to protect drug price status quo, analysis finds

Fierce Pharma

Flag link:

The 340B Program Climbed to $44 Billion in 2021—With Hospitals Grabbing Most of the Money

The 340B Program Climbed to $44 Billion in 2021—With Hospitals Grabbing Most of the Money

Drug Channels

Flag link:

Democrats' drug pricing reforms may not be so bad for pharma, analysts say

Democrats' drug pricing reforms may not be so bad for pharma, analysts say

Fierce Pharma

pharma industry

Flag link:

House sends drug pricing reforms to President Biden’s desk

House sends drug pricing reforms to President Biden’s desk

Stat

Flag link:

The fight is on: As US pricing reform advances through Congress, pharma gears up for a brawl

The fight is on: As US pricing reform advances through Congress, pharma gears up for a brawl

Fierce Pharma

Flag link:

Aduhelm’s loss is a win for value-based drug pricing

Aduhelm’s loss is a win for value-based drug pricing

MedCity News

value-based pricing

Alzheimer's disease

Flag link:

Major drug price reforms head for Biden's signature as PhRMA weighs legal options

Major drug price reforms head for Biden's signature as PhRMA weighs legal options

Endpoints

Flag link:

With drug pricing almost done, Congress looks to wrap up FDA user fee legislation

With drug pricing almost done, Congress looks to wrap up FDA user fee legislation

Endpoints

Flag link:

In a massive victory for Democrats, Medicare is poised to negotiate drug prices

In a massive victory for Democrats, Medicare is poised to negotiate drug prices

Stat

Flag link:

Eli Lilly CEO Ricks echoes a growing refrain on price negotiations: 'We’ll focus our resources on other areas'

Eli Lilly CEO Ricks echoes a growing refrain on price negotiations: 'We’ll focus our resources on other areas'

Endpoints

Flag link:

Pharma CEOs press case against drug price negotiation as bill gains support

Pharma CEOs press case against drug price negotiation as bill gains support

BioPharma Dive

Flag link:

Drug Pricing Debates Heat Up Just in Time for Election Season

Drug Pricing Debates Heat Up Just in Time for Election Season

BioSpace

Inflation Reduction Act

Flag link:

A chaotic sprint to lower insulin prices

A chaotic sprint to lower insulin prices

Stat

Flag link:

With ‘bold experiment’ in drug pricing, Arcutis aims to stand out in plaque psoriasis

With ‘bold experiment’ in drug pricing, Arcutis aims to stand out in plaque psoriasis

MedCity News

Arcutis Biotherapeutics

plaque psoriasis

Flag link:

Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts

Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts

Fierce Pharma

Flag link:

Manchin strikes again: Reconciliation package surfaces, with drug pricing reforms fully intact — for now

Manchin strikes again: Reconciliation package surfaces, with drug pricing reforms fully intact — for now

Endpoints

Flag link:

Out-of-pocket cap will increase the net price of insulin, CBO tells Senate bill sponsors

Out-of-pocket cap will increase the net price of insulin, CBO tells Senate bill sponsors

Endpoints

Flag link:

Pfizer, Flynn Pharma slapped with £70 million fine for massive price hike on epilepsy drug

Pfizer, Flynn Pharma slapped with £70 million fine for massive price hike on epilepsy drug

Fierce Pharma

Flag link:

AstraZeneca, Pfizer, Novartis and more lose out in China's latest round of drug price cuts

AstraZeneca, Pfizer, Novartis and more lose out in China's latest round of drug price cuts

Fierce Pharma

Flag link:

Pages